Home GeneSys

GeneSys

APLICATIONS

New Drug Approval

New Drug Approval | USFDA Approves Vyvgart Hytrulo for Subcutaneous Use...

Harish Chawla - June 22, 2023 0

VYVGART® Hytrulo is the first FDA-approved subcutaneous (SC) injectable for generalized myasthenia gravis (gMG) SAN DIEGO, June 20, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme")...

Job of Medical Representative – Retail Survey

March 28, 2020

New Drug Approval | FDA Approves Colchicine (Lodoco) as First Anti-Inflammatory...

June 20, 2023

Leaves – Types and Details

April 16, 2020

HOT NEWS

Interview Questions

Most Important Questions for Interview Preparation

News & Articles

Heat Stroke | Rising Temperature | Tips to Prevent Heat Stroke

Learning and Development

Leaves – Types and Details

Role and Responsibilities